Adamas Pharmaceuticals
ADMS
#7678
Rank
โ‚ฌ0.31 B
Marketcap
6,90ย โ‚ฌ
Share price
0.00%
Change (1 day)
14,281.42%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): โ‚ฌ74.45 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is โ‚ฌ73.99 Million. In 2020 the company made a revenue of โ‚ฌ62.48 Million an increase over the revenue in the year 2019 that were of โ‚ฌ45.84 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ74.45 M19.16%
2020โ‚ฌ62.48 M36.28%
2019โ‚ฌ45.84 M60.48%
2018โ‚ฌ28.56 M
2016โ‚ฌ0.47 M-70.15%
2015โ‚ฌ1.6 M-96.57%
2014โ‚ฌ46.86 M-21.45%
2013โ‚ฌ59.65 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AbbVie
ABBV
โ‚ฌ50.04 B 67,532.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ53.89 B 72,737.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ35.53 B 47,925.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
โ‚ฌ68.54 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Supernus Pharmaceuticals
SUPN
โ‚ฌ0.57 B 672.82%๐Ÿ‡บ๐Ÿ‡ธ USA